The handling and sampling of radical prostatectomy specimens for reporting and research: the Oxford approach
- PMID: 22872704
- DOI: 10.1136/jclinpath-2012-200923
The handling and sampling of radical prostatectomy specimens for reporting and research: the Oxford approach
Abstract
This article reviews previously described methods of fresh tissue sampling from radical prostatectomy specimens for research and describes a method used in Oxford which is simple, logical and cost effective. The method utilises a systematic zonal approach to tissue procurement in order to meet the increasing requirement for research samples with detailed morphological information such as zone of origin, tumour stage and Gleason grade. The described method involves punch biopsy sampling from a 4mm thick transverse slice cut 8mm superior to the apex. 9 biopsies are taken from each specimen in the following zonal distribution: Mid anterior, right lateral, right peripheral zone lateral, right peripheral zone mid, left peripheral zone mid, left peripheral zone lateral, left lateral, left transition zone and right transition zone. The method was validated by successfully sampling tumour in 7 out of 8 cases (88%). In 6 of the positive cases, tumour was present in more than 1 punch biopsy. The mean time from receipt of the specimen to completion of the biopsy freezing was 23.5 minutes. Tumour stage, zone and Gleason grade were determined for all positive biopsies. All cases were reported to RCPath guidelines with no compromising of margins. A logical systematic method of fresh tissue sampling from radical prostatectomy specimens is presented, which balances the need for accurate routine histopathological reporting with the requirement for increasingly complex research samples to be taken with attention to morphological details such as zone and stage.
Similar articles
-
Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.J Urol. 2002 Aug;168(2):519-24. J Urol. 2002. PMID: 12131301
-
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.J Urol. 2001 Jul;166(1):104-9; discussion 109-10. J Urol. 2001. PMID: 11435833
-
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145152
-
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.Scand J Urol Nephrol Suppl. 2005 May;(216):34-63. doi: 10.1080/03008880510030932. Scand J Urol Nephrol Suppl. 2005. PMID: 16019758 Review.
-
Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.J Urol. 2011 Sep;186(3):790-7. doi: 10.1016/j.juro.2011.02.2695. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788055 Review.
Cited by
-
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.J Immunother Cancer. 2020 Jun;8(1):e000928. doi: 10.1136/jitc-2020-000928. J Immunother Cancer. 2020. PMID: 32591433 Free PMC article. Clinical Trial.
-
Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy.Curr Urol Rep. 2017 Nov 7;18(12):99. doi: 10.1007/s11934-017-0745-0. Curr Urol Rep. 2017. PMID: 29116405 Free PMC article.
-
Ex Vivo Fluorescence Confocal Microscopy (FCM) Ensures Representative Tissue in Prostate Cancer Biobanking: A Feasibility Study.Int J Mol Sci. 2022 Oct 11;23(20):12103. doi: 10.3390/ijms232012103. Int J Mol Sci. 2022. PMID: 36292970 Free PMC article.
-
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.Health Technol Assess. 2020 Aug;24(37):1-176. doi: 10.3310/hta24370. Health Technol Assess. 2020. PMID: 32773013 Free PMC article. Clinical Trial.
-
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.Genome Med. 2024 Feb 19;16(1):35. doi: 10.1186/s13073-024-01302-x. Genome Med. 2024. PMID: 38374116 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous